SCHEMBL12602977

SCHEMBL12602977

CNC(=O)Nc1cc(-c2cccc(NC=O)c2C)cn(C)c1=O

nearest known ligand 0.53

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
BTK Q06187 17/20 0.53
BRD4 O60885 3/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3655731 0.83 BTK (0.54) BTKBRD4
SCHEMBL3655728 0.81 BTK (0.53) BTKBRD4
SCHEMBL104029 0.80 BTK (0.51) BTK
SCHEMBL103964 0.80 BTK (0.81) BTK
SCHEMBL106046 0.79 BTK (0.64) BTK
SCHEMBL105185 0.79 BTK (0.71) BTK
SCHEMBL103127 0.78 BTK (0.67) BTK
SCHEMBL105874 0.77 BTK (0.54) BTK
SCHEMBL108970 0.77 BTK (0.59) BTK
SCHEMBL103347 0.76 BTK (0.57) BTK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7943618-B2 Btk protein kinase inhibitors ROCHE PALO ALTO LLC (US) 2011-05-17 US disclosed
US-20090105209-A1 BTK protein kinase inhibitors ROCHE PALO ALTO LLC 2009-04-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090105209-A1 BTK protein kinase inhibitors BTK, SYK, LYN BTK 1/4885BRD4 196/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.